“Efficacy and safety of Janus Kinase Inhibitors versus Traditional DMARDs in moderate to severe Rheumatoid Arthritis”, Acervo Científico, vol. 25, p. e20772, Jun. 2025, doi: 10.25248/reac.e20772.2025.